Get the Stockscreener App
7.90
2.95%
-0.24
After Hours:
7.90
Contineum Therapeutics Inc Stock (CTNM) Forecast
The Contineum Therapeutics Inc (CTNM) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $7.4381, representing a -5.85% decrease from the current price of $7.90. The highest analyst price target is $8.8481, and the lowest is $6.0281.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CTNM Price Target
Average 7.5795
(-4.06% Downside)
Is Contineum Therapeutics Inc (CTNM) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 23.65 | Buy |
| STOCH(9,6) | 30.83 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -1.4784 | Sell |
| ADX(14) | 39.37 | Sell |
| William %R | -97.07 | Buy |
| CCI(14) | -176.28 | Sell |
Buy: 2
Sell: 4
Neutral: 1
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
11.08
Sell
|
10.36
Sell
|
| MA20 |
11.97
Sell
|
11.68
Sell
|
| MA50 |
14.15
Sell
|
13.21
Sell
|
| MA100 |
13.96
Sell
|
13.63
Sell
|
| MA200 |
13.66
Sell
|
12.96
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CTNM could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 14 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on CTNM, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 23.65 indicates that CTNM is oversold. This indicates that CTNM price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 30.83 indicates that CTNM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that CTNM is oversold. This suggests that CTNM price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 39.37 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -176.28 indicates that CTNM is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term CTNM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Contineum Therapeutics Inc financial reports and earnings history, Contineum Therapeutics Inc (CTNM) stock could reach $6.869 by 2030, $13.23 by 2040 and $42.75 by 2050. See the projected annual prices until 2050 of the Contineum Therapeutics Inc stock below:
- Contineum Therapeutics Inc (CTNM) is expected to reach an average price of $1.7443 in 2035, with a high prediction of $4.1835 and a low estimate of $0.646. This indicates an $-77.92% rise from the last recorded price of $7.90.
- Contineum Therapeutics Inc (CTNM) stock is projected to chart a bullish course in 2040, with an average price target of $13.49, representing an $70.70% surge from its current level. The forecast ranges from a conservative $13.45 to a sky-high $13.23.
- Our analysts predict Contineum Therapeutics Inc (CTNM) to jump 367.73% by 2045, soaring from $37.26 to an average price of $36.95, potentially reaching $36.98. While $37.26 is the low estimate, the potential upside is significant.
- Contineum Therapeutics Inc (CTNM) stock is expected to climb by 2050, reaching an average of $42.96, a $443.82% jump from its current level. However, a wide range of estimates exists, with high and low targets of $42.75 and $41.97, respectively, highlighting the market's uncertainty.
Contineum Therapeutics Inc Stock (CTNM) Year by Year Forecast
Contineum Therapeutics Inc Stock (CTNM) Price Forecast for 2026
The predicted value for Contineum Therapeutics Inc (CTNM) in 2026 is set at an average of $11.91. Estimates vary from a peak of $17.79 to a trough of $6.0281, indicating an +50.72% surge from the present price of $7.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $8.2817 | $6.0281 | $8.8481 | +4.83% |
| December, 2026 | $8.8761 | $7.4289 | $11.38 | +12.36% |
Contineum Therapeutics Inc Stock (CTNM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Contineum Therapeutics Inc (CTNM) is $7.5795, with a high forecast of $14.95 and a low forecast of $0.2121. This indicates an -4.06% decrease from the last price of $7.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $13.74 | $7.5897 | $14.95 | +73.93% |
| February, 2027 | $11.83 | $11.81 | $14.91 | +49.68% |
| March, 2027 | $9.8331 | $9.0387 | $13.71 | +24.47% |
| April, 2027 | $12.42 | $9.6667 | $13.53 | +57.18% |
| May, 2027 | $10.16 | $8.8848 | $12.60 | +28.55% |
| June, 2027 | $7.5801 | $5.8201 | $13.71 | -4.05% |
| July, 2027 | $7.0845 | $6.2245 | $9.7637 | -10.32% |
| August, 2027 | $6.1426 | $5.8926 | $8.929 | -22.25% |
| September, 2027 | $1.5271 | $1.3321 | $6.2512 | -80.67% |
| October, 2027 | $0.5615 | $0.2121 | $1.9657 | -92.89% |
| November, 2027 | $1.9804 | $0.424 | $1.9337 | -74.93% |
| December, 2027 | $1.796 | $1.5982 | $1.606 | -77.27% |
Contineum Therapeutics Inc Stock (CTNM) Price Forecast for 2028
In 2028, Contineum Therapeutics Inc (CTNM) is projected to reach an average price of $5.8679, with a high projection of $11.54 and a low estimate of $0.1919. This indicates an -25.72% fall from the last price of $7.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.0279 | $2.0279 | $2.1165 | -86.99% |
| February, 2028 | $1.7134 | $1.5726 | $1.5684 | -78.31% |
| March, 2028 | $0.181 | $0.919 | $1.4598 | -97.71% |
| April, 2028 | $1.8855 | $0.1919 | $1.9455 | -76.13% |
| May, 2028 | $7.1235 | $1.7892 | $8.1135 | -9.83% |
| June, 2028 | $6.598 | $4.9072 | $7.518 | -16.48% |
| July, 2028 | $5.4961 | $4.8825 | $7.6116 | -30.43% |
| August, 2028 | $6.5605 | $5.0683 | $8.4105 | -16.96% |
| September, 2028 | $6.415 | $5.735 | $7.9327 | -18.80% |
| October, 2028 | $10.14 | $3.6486 | $10.62 | +28.39% |
| November, 2028 | $9.1175 | $8.4375 | $11.54 | +15.41% |
| December, 2028 | $8.392 | $7.0847 | $10.26 | +6.23% |
Contineum Therapeutics Inc Stock (CTNM) Price Forecast for 2029
The 2029 price forecast for Contineum Therapeutics Inc Stock (CTNM) is $6.8814 on average, with a high prediction of $13.73 and a low estimate of $0.0319. This represents an -12.89% decrease from the previous price of $7.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.27 | $7.225 | $9.4106 | +4.68% |
| February, 2029 | $9.4045 | $7.9745 | $11.16 | +19.04% |
| March, 2029 | $7.5789 | $6.7853 | $9.6131 | -4.06% |
| April, 2029 | $9.987 | $7.0325 | $12.60 | +26.42% |
| May, 2029 | $10.04 | $9.0642 | $12.53 | +27.11% |
| June, 2029 | $12.65 | $10.03 | $13.73 | +60.07% |
| July, 2029 | $9.184 | $6.8804 | $12.92 | +16.25% |
| August, 2029 | $0.7472 | $0.0828 | $9.9426 | -90.54% |
| September, 2029 | $1.3261 | $0.0319 | $1.6061 | -83.21% |
| October, 2029 | $1.7523 | $0.2578 | $4.2523 | -77.82% |
| November, 2029 | $6.7112 | $0.4895 | $7.894 | -15.05% |
| December, 2029 | $2.4873 | $2.1273 | $7.9084 | -68.51% |
Contineum Therapeutics Inc Stock (CTNM) Price Forecast for 2030
Contineum Therapeutics Inc Stock (CTNM) is expected to reach an average price of $3.9949 in 2030, with a high forecast of $7.918 and a low forecast of $0.0719. This signifies an -49.43% decrease from the last price of $7.90.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.0162 | $2.1845 | $6.869 | -61.82% |
| February, 2030 | $5.6951 | $2.8735 | $6.7607 | -27.91% |
| March, 2030 | $3.434 | $2.2096 | $5.9024 | -56.53% |
| April, 2030 | $1.0702 | $0.6898 | $7.173 | -86.45% |
| May, 2030 | $0.6691 | $0.0719 | $3.2774 | -91.53% |
| June, 2030 | $0.648 | $0.173 | $2.608 | -91.80% |
| July, 2030 | $4.6759 | $0.4048 | $3.4059 | -40.81% |
| August, 2030 | $5.547 | $5.3186 | $4.8142 | -29.79% |
| September, 2030 | $7.9708 | $5.1175 | $6.0808 | +0.90% |
| October, 2030 | $7.6919 | $7.5414 | $7.5019 | -2.63% |
| November, 2030 | $7.943 | $8.1047 | $7.918 | +0.54% |
| December, 2030 | $7.3969 | $7.3269 | $7.2519 | -6.37% |
1.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):